John Robinson, Department of Chemistry, UZH
Andreas Plückthun, Department of Biochemistry, UZH
Amedeo Caflisch and Milan Vasak, Department of Biochemistry, UZH
Markus Grütter, prev. Department of Biochemistry, UZH (yes, crystallographers and NMR spectroscopists can work together productively!)
Peter Hamm, Department of Chemistry, UZH
Eva Freisinger, Department of Chemistry, UZH
Alex Sartori, Cancer Research Institute, UZH
Martin Baumgartner, Oncology Department at Children's Hospital, UZH
Fred Naider, CUNY College of Staten Island, New York
Jeff Becker, University of Tennessee, on the Ste2p GPCR project
Peter Güntert, University of Frankfurt/ETH Zürich, who always supports us on computational aspects of NMR
Reinhard Dallinger, University of Innsbruck, ongoing joint efforts on the metallothionein project
The late Siliva Atrian, University of Barcelona
Merce Capdevila, Universitat Autònoma de Barcelona
Luca Varani, IRB in Bellinzona, on antibody-related research
Dan Scott, Florey Institute in Melbourne, provided stabilized GPCRs
Daniel Häussinger, University of Basel, on the use of spin-labels for measuring pseudo-contact shifts
Jürgen Scherkenbeck (Wuppertal) on insect hormones
Knud Jensen from Copenhagen on neuropeptides
Jörg Kleinschmidt from Konstanz on beta-barrel proteins
Marina Rubini from Konstanz on the incorporation of unnnatural amino acids into proteins
Hans-Robert Kalbitzer (Regensburg) on high pressure studies
Ismael Mingarro (Alicante) on topological studies of GPCR fragments.
Gerd Folkers (prev. ETH) together with Annette Beck-Sickinger (Leipzig) on the NPY project
Hans-Peter Merkle (prev. ETH) on projects concerning delivery of drugs
I had the opportunity to work in the distinguished lab of Nobel Laureate Kurt Wüthrich, and support on the spectroscopic part from Gerhard Wider is deeply acknowledged.
I am sure I forgot to name a few, I apologize...
I would also like to acknowledge fruitful discussions with members of industry: Marcel Blommers (Saverna), Wolfgang Jahnke (Novartis), Cesar Fernandez (Novartis) and Alvar Gossert (ETHZ, previously at Novartis) as well as with Hans Senn, Alfred Ross and Werner Klaus from Hoffman LaRoche.